Enclomiphene vs Pregnenolone
A side-by-side research comparison of Enclomiphene and Pregnenolone across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Enclomiphene | Pregnenolone |
|---|---|---|
| Full name | Enclomiphene Citrate | Pregnenolone (Mother Hormone) |
| Category | Hormone Replacement | Hormone Replacement |
| Status | Investigational drug | OTC supplement / Prescribed |
| Mechanism | Blocks estrogen receptors in the hypothalamus, reducing negative feedback and increasing GnRH pulsatility, which stimulates LH and FSH release for endogenous testosterone production. | Acts as the primary substrate for steroidogenesis (cortisol, DHEA, progesterone, testosterone, estrogen). Also functions as a neurosteroid, enhancing memory and NMDA receptor activity. |
| Molecular weight | 598.09 Da | 316.48 Da |
| Half-life | 10-14 hours | ~1-3 hours (oral) |
| Bioavailability | ~50% oral | ~60% oral |
| Typical dose | 12.5-25 mg | 50-100 mg |
| Frequency | Daily | Daily (morning) |
| Route | Oral capsule | Oral capsule or sublingual |
Enclomiphene reported benefits
- Increased endogenous testosterone
- Preserved fertility
- Improved libido
- Enhanced energy and mood
- No testicular atrophy
Pregnenolone reported benefits
- Hormone precursor balance
- Memory enhancement
- Mood improvement
- Joint support
- Myelin sheath repair
- Stress resilience
Related comparisons
Research and educational reference only. Not medical advice.